VENA, ANTONIO
VENA, ANTONIO
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
2020 Bassetti, Matteo; Vena, Antonio; Giacobbe, Daniele Roberto; Falcone, Marco; Tiseo, Giusy; Giannella, Maddalena; Pascale, Renato; Meschiari, Marianna; Digaetano, Margherita; Oliva, Alessandra; Rovelli, Cristina; Carannante, Novella; Losito, Angela Raffaella; Carbonara, Sergio; Mariani, Michele Fabiano; Mastroianni, Antonio; Angarano, Gioacchino; Tumbarello, Mario; Tascini, Carlo; Grossi, Paolo; Mastroianni, Claudio Maria; Mussini, Cristina; Viale, Pierluigi; Menichetti, Francesco; Viscoli, Claudio; Russo, Alessandro; CEFTABUSE Study, Group
Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa
2020 Vena, A.; Giacobbe, D. R.; Mussini, C.; Cattelan, A.; Bassetti, M.; Ceftabuse Study, Group; Oliva, A.
Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia
2004 Antonella, Tosti; Pazzaglia, Mariella; Marcello, Soli; Rossi, Alfredo; Alfredo, Rebora; Laura, Atzori; Mauro, Barbareschi; Maurizio, Benci; Stylianos, Voudouris; Vena, Antonio
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience
2011 Russo, A; Falcone, M; Vena, A; Venditti, C; Mancini, C; Morelli, A; Venditti, M
Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy
2012 Falcone, Marco; Russo, Alessandro; Maria Elena, Pompeo; Vena, Antonio; Marruncheddu, Laura; Ciccaglioni, Antonio; Paolo, Grossi; Mancini, Carlo; Andrea, Novelli; Stefania, Stefani; Venditti, Mario
Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae
2014 Falcone, Marco; Vena, Antonio; M. L., Mezzatesta; F., Gona; C., Caio; Goldoni, Paola; Trancassini, Maria; Conti, Cinzia; Orsi, Giovanni Battista; P., Carfagna; S., Stefani; Venditti, Mario
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections
2021 Bassetti, Matteo; Falletta, Antonio; Cenderello, Giovanni; Giacobbe, Daniele R.; Vena, Antonio
Streptococcus anginosus group disseminated infection: case report and review of literature.
2012 Giuliano, Simone; G., Simone; G., Rubini; A., Conte; Goldoni, Paola; Falcone, Marco; Vena, Antonio; Venditti, Mario; S., Morelli
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) | 2020 | Bassetti, Matteo; Vena, Antonio; Giacobbe, Daniele Roberto; Falcone, Marco; Tiseo, Giusy; Giannella, Maddalena; Pascale, Renato; Meschiari, Marianna; Digaetano, Margherita; Oliva, Alessandra; Rovelli, Cristina; Carannante, Novella; Losito, Angela Raffaella; Carbonara, Sergio; Mariani, Michele Fabiano; Mastroianni, Antonio; Angarano, Gioacchino; Tumbarello, Mario; Tascini, Carlo; Grossi, Paolo; Mastroianni, Claudio Maria; Mussini, Cristina; Viale, Pierluigi; Menichetti, Francesco; Viscoli, Claudio; Russo, Alessandro; CEFTABUSE Study, Group | |
| Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa | 2020 | Vena, A.; Giacobbe, D. R.; Mussini, C.; Cattelan, A.; Bassetti, M.; Ceftabuse Study, Group; Oliva, A. | |
| Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia | 2004 | Antonella, Tosti; Pazzaglia, Mariella; Marcello, Soli; Rossi, Alfredo; Alfredo, Rebora; Laura, Atzori; Mauro, Barbareschi; Maurizio, Benci; Stylianos, Voudouris; Vena, Antonio | |
| Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience | 2011 | Russo, A; Falcone, M; Vena, A; Venditti, C; Mancini, C; Morelli, A; Venditti, M | |
| Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy | 2012 | Falcone, Marco; Russo, Alessandro; Maria Elena, Pompeo; Vena, Antonio; Marruncheddu, Laura; Ciccaglioni, Antonio; Paolo, Grossi; Mancini, Carlo; Andrea, Novelli; Stefania, Stefani; Venditti, Mario | |
| Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae | 2014 | Falcone, Marco; Vena, Antonio; M. L., Mezzatesta; F., Gona; C., Caio; Goldoni, Paola; Trancassini, Maria; Conti, Cinzia; Orsi, Giovanni Battista; P., Carfagna; S., Stefani; Venditti, Mario | |
| Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections | 2021 | Bassetti, Matteo; Falletta, Antonio; Cenderello, Giovanni; Giacobbe, Daniele R.; Vena, Antonio | |
| Streptococcus anginosus group disseminated infection: case report and review of literature. | 2012 | Giuliano, Simone; G., Simone; G., Rubini; A., Conte; Goldoni, Paola; Falcone, Marco; Vena, Antonio; Venditti, Mario; S., Morelli |